Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IRADIMED CORP | 2,165,333 | reported | 27 May 2026 | tx 236+21,000−2,608,050 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | SALE | IRADIMED CORP | 3,111 | 91.81 USD | 10b5-1 |
| 26 May 2026 | SALE | IRADIMED CORP | 1,889 | 92.93 USD | 10b5-1 |
| 27 May 2026 | SALE | IRADIMED CORP | 2,167 | 91.85 USD | 10b5-1 |
| 27 May 2026 | SALE | IRADIMED CORP | 333 | 92.61 USD | 10b5-1 |
| 18 May 2026 | SALE | IRADIMED CORP | 298 | 85.95 USD | 10b5-1 |
| 18 May 2026 | SALE | IRADIMED CORP | 3,451 | 87.35 USD | 10b5-1 |
| 18 May 2026 | SALE | IRADIMED CORP | 1,251 | 88.34 USD | 10b5-1 |
| 19 May 2026 | SALE | IRADIMED CORP | 653 | 87.13 USD | 10b5-1 |
| 19 May 2026 | SALE | IRADIMED CORP | 1,841 | 88.14 USD | 10b5-1 |
| 19 May 2026 | SALE | IRADIMED CORP | 6 | 88.65 USD | 10b5-1anomaly |
| 11 May 2026 | SALE | IRADIMED CORP | 1,773 | 84.08 USD | 10b5-1 |
| 11 May 2026 | SALE | IRADIMED CORP | 1,001 | 84.94 USD | 10b5-1 |
| 11 May 2026 | SALE | IRADIMED CORP | 315 | 85.90 USD | 10b5-1 |
| 12 May 2026 | SALE | IRADIMED CORP | 3,307 | 83.70 USD | 10b5-1 |
| 12 May 2026 | SALE | IRADIMED CORP | 1,104 | 84.59 USD | 10b5-1 |
| 04 May 2026 | SALE | IRADIMED CORP | 2,447 | 85.32 USD | 10b5-1 |
| 04 May 2026 | SALE | IRADIMED CORP | 1,103 | 86.26 USD | 10b5-1 |
| 04 May 2026 | SALE | IRADIMED CORP | 200 | 87.05 USD | 10b5-1 |
| 05 May 2026 | SALE | IRADIMED CORP | 600 | 83.78 USD | 10b5-1 |
| 05 May 2026 | SALE | IRADIMED CORP | 1,322 | 85.56 USD | 10b5-1 |
| 05 May 2026 | SALE | IRADIMED CORP | 1,650 | 86.43 USD | 10b5-1 |
| 05 May 2026 | SALE | IRADIMED CORP | 178 | 87.31 USD | 10b5-1 |
| 27 Apr 2026 | SALE | IRADIMED CORP | 2,819 | 88.98 USD | 10b5-1 |
| 27 Apr 2026 | SALE | IRADIMED CORP | 931 | 89.70 USD | 10b5-1 |
| 28 Apr 2026 | SALE | IRADIMED CORP | 998 | 84.13 USD | 10b5-1 |
1 purchase reported after at least 12 months of silence — most recent on 16 Mar 2018.